Antibacterials: cell envelope antibiotics (J01C-J01D) | |||
---|---|---|---|
Intracellular | inhibit peptidoglycan subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin) • DADAL/AR inhibitors (Cycloserine) • bactoprenol inhibitors (Bacitracin) | ||
Glycopeptide | inhibit PG chain elongation: Vancomycin# (Oritavancin, Telavancin) • Teicoplanin (Dalbavancin) • Ramoplanin | ||
β-lactams/ (inhibit PBP cross-links) | |||
Other | polymyxins/detergent (Colistin, Polymyxin B) • depolarizing (Daptomycin) • hydrolyze NAM-NAG (Lysozyme) • Gramicidin | ||
#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III |